{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:10:37Z","timestamp":1768993837350,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.vaccine.2012.06.011","type":"journal-article","created":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T03:54:41Z","timestamp":1339991681000},"page":"5206-5214","source":"Crossref","is-referenced-by-count":64,"title":["Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles"],"prefix":"10.1016","volume":"30","author":[{"given":"S.","family":"Garlapati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Brownlie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Latimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Simko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.E.W.","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.A.","family":"Babiuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Gerdts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"van Drunen Littel-van den Hurk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.06.011_bib0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/317655","article-title":"Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979\u20131997","volume":"183","author":"Shay","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.06.011_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2012.01.008","article-title":"Pathogenesis of respiratory syncytial virus","volume":"2","author":"Van Drunen Littel-van den Hurk","year":"2012","journal-title":"Curr Opin Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2012.06.011_bib0015","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N Engl J Med"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.06.011_bib0020","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2012.06.011_bib0025","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1128\/JVI.01625-07","article-title":"Viral and host factors in human respiratory syncytial virus pathogenesis","volume":"82","author":"Collins","year":"2008","journal-title":"J Virol"},{"issue":"Jun (11\u201312)","key":"10.1016\/j.vaccine.2012.06.011_bib0030","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.drudis.2009.02.009","article-title":"The path to a successful vaccine adjuvant\u2014\u2018the long and winding road\u2019","volume":"14","author":"O\u2019Hagan","year":"2009","journal-title":"Drug Discov Today"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.06.011_bib0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nm.1894","article-title":"Lack of antibody affinity maturation due to poor toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease","volume":"15","author":"Delgado","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2012.06.011_bib0040","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CpG motifs in bacterial DNA and their immune effects","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu Rev Immunol"},{"issue":"March (14)","key":"10.1016\/j.vaccine.2012.06.011_bib0045","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.vaccine.2009.01.118","article-title":"The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice","volume":"27","author":"Kovacs-Nolan","year":"2009","journal-title":"Vaccine"},{"issue":"March (14)","key":"10.1016\/j.vaccine.2012.06.011_bib0050","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.vaccine.2009.01.117","article-title":"CpG oligonucleotide, host defense peptide and polyphosphazene act synergistically, inducing long-lasting, balanced immune responses in cattle","volume":"27","author":"Kovacs-Nolan","year":"2009","journal-title":"Vaccine"},{"issue":"August (Pt. 8)","key":"10.1016\/j.vaccine.2012.06.011_bib0055","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1099\/vir.0.011684-0","article-title":"Formulation of bovine respiratory syncytial virus fusion protein with CpG oligodeoxynucleotide, cationic host defence peptide and polyphosphazene enhances humoral and cellular responses and induces a protective type 1 immune response in mice","volume":"90","author":"Kovacs-Nolan","year":"2009","journal-title":"J Gen Virol"},{"issue":"July (34)","key":"10.1016\/j.vaccine.2012.06.011_bib0060","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1016\/j.vaccine.2009.05.094","article-title":"A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity","volume":"27","author":"Kindrachuk","year":"2009","journal-title":"Vaccine"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2012.06.011_bib0065","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1128\/JVI.79.4.2024-2032.2005","article-title":"Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine","volume":"79","author":"Oumouna","year":"2005","journal-title":"J Virol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.06.011_bib0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.addr.2008.12.013","article-title":"Innovative strategies for co-delivering antigens and CpG oligonucleotides","volume":"61","author":"Krishnamachari","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2012.06.011_bib0075","first-page":"1","article-title":"Multifunctional cationic host defence peptides and their clinical applications","author":"Yeung","year":"2011","journal-title":"Cell Mol Life Sci"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2012.06.011_bib0080","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.4049\/jimmunol.0901813","article-title":"Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment","volume":"184","author":"Nijnik","year":"2010","journal-title":"J Immunol"},{"issue":"November (45)","key":"10.1016\/j.vaccine.2012.06.011_bib0085","doi-asserted-by":"crossref","first-page":"18936","DOI":"10.1073\/pnas.0908842106","article-title":"Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization","volume":"106","author":"Andrianov","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"December (38)","key":"10.1016\/j.vaccine.2012.06.011_bib0090","first-page":"6540","article-title":"PCPP (poly[di(carboxylatophenoxy)-phosphazene]) microparticles co-encapsulating ovalbumin and CpG oligo-deoxynucleotides are potent enhancers of antigen specific Th1 immune responses in mice","volume":"29","author":"Garlapati","year":"2010","journal-title":"Vaccine"},{"issue":"September (52)","key":"10.1016\/j.vaccine.2012.06.011_bib0095","first-page":"8306","article-title":"PCPP (poly[di(carboxylatophenoxy)-phosphazene]) microparticles co-encapsulating ovalbumin and CpG oligo-deoxynucleotides are potent enhancers of antigen specific Th1 immune responses in mice","volume":"28","author":"Garlapati","year":"2011","journal-title":"Vaccine"},{"issue":"January (Pt. 1)","key":"10.1016\/j.vaccine.2012.06.011_bib0100","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1099\/vir.0.83300-0","article-title":"Intranasal immunization of mice with a formalin-inactivated bovine respiratory syncytial virus vaccine co-formulated with CpG oligodeoxynucleotides and polyphosphazenes results in enhanced protection","volume":"89","author":"Mapletoft","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2012.06.011_bib0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1743-422X-4-51","article-title":"Expression of RNA virus proteins by RNA polymerase II dependent expression plasmids is hindered at multiple steps","volume":"4","author":"Ternette","year":"2007","journal-title":"Virol J"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.06.011_bib0110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1099\/vir.0.83300-0","article-title":"Intranasal immunization of mice with a formalin-inactivated bovine respiratory syncytial virus vaccine co-formulated with CpG oligodeoxynucleotides and polyphosphazenes results in enhanced protection","volume":"89","author":"Mapletoft","year":"2008","journal-title":"J Gen Virol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.06.011_bib0115","first-page":"1385","article-title":"Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus)","volume":"79","author":"Prince","year":"1999","journal-title":"Lab Invest: J Tech Methods Pathol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.06.011_bib0120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-065X.2010.00972.x","article-title":"Biological challenges and technological opportunities for respiratory syncytial virus vaccine development","volume":"239","author":"Graham","year":"2011","journal-title":"Immunol Rev"},{"issue":"August (33)","key":"10.1016\/j.vaccine.2012.06.011_bib0125","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1016\/j.vaccine.2007.05.068","article-title":"Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model","volume":"25","author":"Singh","year":"2007","journal-title":"Vaccine"},{"issue":"June (23)","key":"10.1016\/j.vaccine.2012.06.011_bib0130","doi-asserted-by":"crossref","first-page":"9619","DOI":"10.1073\/pnas.1106536108","article-title":"Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers","volume":"108","author":"Swanson","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2012.06.011_bib0135","doi-asserted-by":"crossref","first-page":"10287","DOI":"10.1128\/JVI.74.22.10287-10292.2000","article-title":"Efficacy and safety studies of a recombinant chimeric respiratory syncytial virus FG glycoprotein vaccine in cotton rats","volume":"74","author":"Prince","year":"2000","journal-title":"J Virol"},{"issue":"September (32)","key":"10.1016\/j.vaccine.2012.06.011_bib0140","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1016\/S0264-410X(01)00228-6","article-title":"CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV)","volume":"19","author":"Hancock","year":"2001","journal-title":"Vaccine"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2012.06.011_bib0145","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.vaccine.2011.11.054","article-title":"Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands","volume":"30","author":"Shafique","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2012.06.011_bib0150","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.addr.2009.11.009","article-title":"Chitosan-based delivery systems for protein therapeutics and antigens","volume":"62","author":"Amidi","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.06.011_bib0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1586\/erv.10.154","article-title":"Combination adjuvants: the next generation of adjuvants?","volume":"10","author":"Mutwiri","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"July\u2013August (4)","key":"10.1016\/j.vaccine.2012.06.011_bib0160","first-page":"405","article-title":"Nanoparticle vaccines against respiratory viruses","volume":"1","author":"Adair","year":"2009","journal-title":"Wiley Interdiscip Rev"},{"issue":"October (46)","key":"10.1016\/j.vaccine.2012.06.011_bib0165","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1016\/j.vaccine.2009.06.019","article-title":"Respiratory syncytial virus subunit vaccine based on a recombinant fusion protein expressed transiently in mammalian cells","volume":"27","author":"Nallet","year":"2009","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2012.06.011_bib0170","doi-asserted-by":"crossref","first-page":"e21823","DOI":"10.1371\/journal.pone.0021823","article-title":"A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease","volume":"6","author":"Lindell","year":"2011","journal-title":"PloS One"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2012.06.011_bib0175","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.4049\/jimmunol.173.7.4627","article-title":"Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848","volume":"173","author":"Levy","year":"2004","journal-title":"J Immunol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2012.06.011_bib0180","doi-asserted-by":"crossref","first-page":"012002","DOI":"10.1103\/PhysRevLett.97.012002","article-title":"Measurement of the Bc+ meson lifetime using the decay mode Bc+\u2192J\/Psie+nue","volume":"97","author":"Abulencia","year":"2006","journal-title":"Phys Rev Lett"},{"issue":"1","key":"10.1016\/j.vaccine.2012.06.011_bib0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1574-695X.2001.tb00535.x","article-title":"CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice","volume":"32","author":"Weeratna","year":"2001","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"April","key":"10.1016\/j.vaccine.2012.06.011_bib0190","article-title":"Imidazoquinoline toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways","author":"Philbin","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2012.06.011_bib0195","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.vaccine.2010.12.083","article-title":"Antibody responses in adult and neonatal BALB\/c mice to immunization with novel Bordetella pertussis vaccine formulations","volume":"29","author":"Gracia","year":"2011","journal-title":"Vaccine"},{"issue":"December (52)","key":"10.1016\/j.vaccine.2012.06.011_bib0200","doi-asserted-by":"crossref","first-page":"8288","DOI":"10.1016\/j.vaccine.2010.10.006","article-title":"A novel triple adjuvant formulation promotes strong, Th1-biased immune responses and significant antigen retention at the site of injection","volume":"28","author":"Wilson","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1200850X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1200850X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T21:40:37Z","timestamp":1561844437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1200850X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":40,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0264410X1200850X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.06.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}